Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
24.94
+0.16 (0.65%)
Sep 2, 2026, 10:59 AM EDT - Market open
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $7.05 billion as of September 2, 2026. Its market cap has decreased by -34.72% in one year.
Market Cap
7.05B
Enterprise Value
6.71B
1-Year Change
-34.72%
Ranking
Category
Stock Price
$24.94
ChartMarket Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $7.05B, an increase of 18.36%. That is a compound annual growth rate of 14.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 7.05B | -7.41% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 8.53B |
| Immunovant | 8.51B |
| Spyre Therapeutics | 7.97B |
| TG Therapeutics | 7.65B |
| Rhythm Pharmaceuticals | 7.38B |
| Scholar Rock Holding | 7.04B |
| CG Oncology | 6.59B |
| Mirum Pharmaceuticals | 6.33B |